These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 16715566
1. Does assessment of medical practices have a future? Capron AM. Va Law Rev; 1996 Nov; 82(8):1623-40. PubMed ID: 16715566 [No Abstract] [Full Text] [Related]
2. The limited regulatory potential of medical technology assessment. Elhauge E. Va Law Rev; 1996 Nov; 82(8):1525-1622. PubMed ID: 16715565 [No Abstract] [Full Text] [Related]
3. Medicare and cost-effectiveness analysis. Neumann PJ, Rosen AB, Weinstein MC. N Engl J Med; 2005 Oct 06; 353(14):1516-22. PubMed ID: 16207857 [No Abstract] [Full Text] [Related]
6. Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis. Eddy D. Health Aff (Millwood); 2007 Oct 06; 26(4):w500-15. PubMed ID: 17580317 [Abstract] [Full Text] [Related]
8. Technology assessment and cost-effectiveness analysis: misguided guidelines? Naylor CD, Williams JI, Basinski A, Goel V. CMAJ; 1993 Mar 15; 148(6):921-4. PubMed ID: 8448706 [No Abstract] [Full Text] [Related]
10. Medicare and cost-effectiveness analysis. Berger M, Honig P, Spatz I. N Engl J Med; 2006 Jan 12; 354(2):207-9; author reply 207-9. PubMed ID: 16411304 [No Abstract] [Full Text] [Related]
11. The physicians' peer review program--does it cost more than it saves? Demkovich LE. Natl J (Wash); 1980 May 03; 12(18):733-6. PubMed ID: 10309147 [No Abstract] [Full Text] [Related]
12. Perspectives. Assessing medical technology. Glenn KJ. Mcgraw Hills Med Health; 1989 Jun 05; 43(22):suppl 4 p.. PubMed ID: 10313116 [No Abstract] [Full Text] [Related]
13. Medical necessity: trying to reach consensus. Phillips L. Hosp Technol Ser; 1996 May 05; 15(6):5, 10. PubMed ID: 10158519 [No Abstract] [Full Text] [Related]
14. Technology assessment and the doctor-patient relationship. Wax AL. Va Law Rev; 1996 Nov 05; 82(8):1641-62. PubMed ID: 16715567 [No Abstract] [Full Text] [Related]
15. Prioritizing investments in health: can we assess potential value for money? Drummond M. J Rheumatol Suppl; 2003 Dec 05; 68():19-20. PubMed ID: 14712616 [No Abstract] [Full Text] [Related]
16. Reimbursing new technologies: why are the courts judging experimental medicine? Saver RS. Stanford Law Rev; 1992 May 05; 44(5):1095-131. PubMed ID: 10119850 [No Abstract] [Full Text] [Related]
17. What if technology never stops improving? Medicare's future under continuous cost increases. Pauly MV. Wash Lee Law Rev; 2003 May 05; 60(4):1233-50. PubMed ID: 16211762 [No Abstract] [Full Text] [Related]
18. Medical technology assessment: economic evaluation of new technologies. Adang EM, Dirksen CD, Engel GL, Baeten CG. Br J Hosp Med; 2003 May 05; 53(11):563-6. PubMed ID: 7655753 [Abstract] [Full Text] [Related]
19. [Economic evaluation of medical therapy--methodological principles]. Szucs TD, Schramm W. Zentralbl Chir; 1995 May 05; 120(8):577-83. PubMed ID: 7571888 [Abstract] [Full Text] [Related]
20. When an insurer calls your treatment experimental. Holoweiko M. Med Econ; 1995 Sep 11; 72(17):171-2, 175-6, 178-82. PubMed ID: 10151340 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]